Catherine Novack
Stock Analyst at Jones Trading
(2.18)
# 3,023
Out of 5,182 analysts
25
Total ratings
23.81%
Success rate
6.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DTIL Precision BioSciences | Assumes: Buy | $30 | $7.03 | +326.74% | 1 | Apr 17, 2026 | |
| IBIO iBio, Inc. | Initiates: Buy | $7 | $1.71 | +309.36% | 1 | Mar 3, 2026 | |
| SEPN Septerna | Initiates: Buy | $43 | $25.07 | +71.55% | 1 | Dec 23, 2025 | |
| KRRO Korro Bio | Downgrades: Hold | n/a | $12.84 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $5.52 | +497.83% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $18.04 | +66.30% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $35.10 | -17.38% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.39 | +1,433.74% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $8.78 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $128.64 | -65.02% | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.49 | +638.26% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.04 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $6.94 | +130.55% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.44 | +215.32% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.24 | +480.36% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.31 | +202.11% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $0.59 | +3,628.18% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.29 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,600 | $4.59 | +34,758.39% | 1 | Jul 21, 2023 |
Precision BioSciences
Apr 17, 2026
Assumes: Buy
Price Target: $30
Current: $7.03
Upside: +326.74%
iBio, Inc.
Mar 3, 2026
Initiates: Buy
Price Target: $7
Current: $1.71
Upside: +309.36%
Septerna
Dec 23, 2025
Initiates: Buy
Price Target: $43
Current: $25.07
Upside: +71.55%
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $12.84
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $5.52
Upside: +497.83%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $18.04
Upside: +66.30%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $35.10
Upside: -17.38%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.39
Upside: +1,433.74%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $8.78
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $128.64
Upside: -65.02%
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.49
Upside: +638.26%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.04
Upside: -
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.94
Upside: +130.55%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $4.44
Upside: +215.32%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.24
Upside: +480.36%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $3.31
Upside: +202.11%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $0.59
Upside: +3,628.18%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $7.29
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $1,600
Current: $4.59
Upside: +34,758.39%